Table 1. Demographic and anthropometric baseline data by treatment and HIV-status.
Placebo | 5 µg RUTI | 25 µg RUTI | 50 µg RUTI | |||||
HIV− | HIV+ | HIV− | HIV+ | HIV− | HIV+ | HIV− | HIV+ | |
(n = 12) | (n = 12) | (n = 12) | (n = 11) | (n = 12) | (n = 12) | (n = 12) | (n = 12) | |
Age (years); mean (SD) | 32.8 (9.4) | 35.7 (7.8) | 35.8 (9.4) | 33.0 (6.3) | 36.1 (11.0) | 31.2 (7.3) | 32.1 (8.5) | 32.9 (8.6) |
Ethic origin (%) | ||||||||
African | 66.7 | 66.7 | 66.7 | 72.7 | 50.0 | 100.0 | 83.3 | 91.7 |
Others | 33.3 | 33.3 | 25.0 | 18.2 | 50.0 | 0.0 | 16.7 | 8.3 |
Female (%) | 83.3 | 83.3 | 41.7 | 72.7 | 58.3 | 91.7 | 41.7 | 83.3 |
Weight (kg);mean (SD) | 74.2 (13.8) | 69.1 (13.2) | 75.9 (16.3) | 74.7 (21.5) | 83.8 (22.0) | 76.6 (14.6) | 75.1 (19.4) | 71.8 (9.8) |
SD, standard deviation.